Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
Kurtz George0B / 220S220 trades$52.89M
Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
TSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
DRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
MTDRMatador Resources CoNov 5 – Nov 109 insiders$765K
MSIMotorola Solutions, Inc.Nov 6 – Nov 108 insiders$40.91M
FFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
MGNIMAGNITE, INC.Nov 5 – Nov 127 insiders$2.27M
SYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
UPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 9 | Lizzul Paul F.Chief Medical Officer |  TRAXFirst Tracks Biotherapeutics, Inc.Grant or award | A | — 25.6K sh | Apr 22, 2026 |
| 9 | Faga DanielDirector, President, CEO | TRAXFirst Tracks Biotherapeutics, Inc. Grant or award | A | — 133.4K sh | Apr 22, 2026 traded Apr 20, 2026 |
| 9 | Stephenson DaveDirector |  LYFTLyft, Inc.Grant or award | A | — 1,127 sh | Apr 22, 2026 traded Apr 20, 2026 |
| 9 | Otitoju Kolawole A.Chief Bus. & Strategy Officer |  MASS908 Devices Inc.Grant or award | A | — 110.2K sh | Apr 22, 2026 traded Apr 21, 2026 |
| 9 | Prahm JeremyChief Investment Officer |  FOAFinance of America Companies Inc.Open-market sale · 10b5-1 plan | SELL | $138K 6,000 sh | Apr 22, 2026 traded Apr 20, 2026 |
| 9 | Ware J. AnthonyDirector | TRAXFirst Tracks Biotherapeutics, Inc. Grant or award | A | — 16.5K sh | Apr 22, 2026 traded Apr 20, 2026 |
| 9 | Ware J. AnthonyDirector | TRAXFirst Tracks Biotherapeutics, Inc. Grant or award | A | — 16.5K sh | Apr 22, 2026 traded Apr 20, 2026 |
| 9 | Faga DanielDirector, President, CEO | TRAXFirst Tracks Biotherapeutics, Inc. Grant or award | A | — 11.0K sh | Apr 22, 2026 traded Apr 20, 2026 |
| 9 | Faga DanielDirector, President, CEO | TRAXFirst Tracks Biotherapeutics, Inc. Grant or award | A | — 2,321 sh | Apr 22, 2026 traded Apr 20, 2026 |
| 9 | Pulik RichardCFO |  ROIVRoivant Sciences Ltd.Grant or award | A | — 84.0K sh | Apr 22, 2026 traded Apr 20, 2026 |
| 9 | Low Check KianDirector |  AVGOBroadcom Inc.Grant or award | A | — 864 sh | Apr 22, 2026 traded Apr 20, 2026 |
| 9 | Faga DanielDirector, President, CEO | TRAXFirst Tracks Biotherapeutics, Inc. Grant or award | A | — 80.5K sh | Apr 22, 2026 traded Apr 20, 2026 |
| 9 | Jones Mark E. Jr.President & COO, 10% Owner, Member of 10% owner group |  GSHDGoosehead Insurance, Inc.Grant or award | A | — 50.0K sh | Apr 22, 2026 traded Apr 20, 2026 |
| 9 | Ware J. AnthonyDirector | TRAXFirst Tracks Biotherapeutics, Inc. Grant or award | A | — 28.6K sh | Apr 22, 2026 traded Apr 20, 2026 |
| 9 | Williams Stephen D.Director |  HCCWARRIOR MET COAL, INC.Grant or award | A | — 1,423 sh | Apr 22, 2026 traded Apr 20, 2026 |
| 9 | Marquet MagdaDirector | TRAXFirst Tracks Biotherapeutics, Inc. Grant or award | A | — 16.5K sh | Apr 22, 2026 traded Apr 20, 2026 |
| 9 | Marquet MagdaDirector | TRAXFirst Tracks Biotherapeutics, Inc. Grant or award | A | — 5,500 sh | Apr 22, 2026 traded Apr 20, 2026 |
| 9 | Whiteside JaneyDirector | LYFTLyft, Inc. Grant or award | A | — 928 sh | Apr 22, 2026 traded Apr 20, 2026 |
| 8 | Collins Charles Edwin IVCHIEF EXECUTIVE OFFICER, GEMMA |  AGXARGAN INCOption exercise | M | $177K 5,235 sh | Apr 22, 2026 traded Apr 21, 2026 |
| 8 | O'Hara John CharlesDirector, Chief Financial Officer |  LAESSEALSQ CorpOpen-market sale · 10b5-1 plan | SELL | $28K 10.0K sh | Apr 22, 2026 traded Apr 20, 2026 |
| 8 | O'Hara John CharlesDirector, Chief Financial Officer | LAESSEALSQ Corp Open-market sale · 10b5-1 plan | SELL | $30K 10.0K sh | Apr 22, 2026 traded Apr 21, 2026 |
| 8 | Jeffrey John Ronald Jr.Director | AGXARGAN INC Option exercise | M | $174K 4,698 sh | Apr 22, 2026 traded Apr 21, 2026 |
| 6 | Fang AndyDirector | DASHDoorDash, Inc. Grant or award | A | — 4,869 sh | Apr 22, 2026 traded Apr 20, 2026 |
| 6 | Tang StanleyDirector | DASHDoorDash, Inc. Grant or award | A | — 3,124 sh | Apr 22, 2026 traded Apr 20, 2026 |
| 6 | Kirol Charles PeterChief Operating Officer |  PTONPELOTON INTERACTIVE, INC.Open-market sale · 10b5-1 plan | SELL | $19K 3,670 sh | Apr 22, 2026 traded Apr 20, 2026 |
| 6 | Cross ShawnChief Financial Officer |  PCRXPacira BioSciences, Inc.Option exercise · 10b5-1 plan | M | $127K 7,714 sh | Apr 22, 2026 traded Apr 20, 2026 |
| 5 | Collins Charles Edwin IVCHIEF EXECUTIVE OFFICER, GEMMA | AGXARGAN INC Option exercise | M | $50K 333 sh | Apr 22, 2026 traded Apr 21, 2026 |
| 5 | Collins Charles Edwin IVCHIEF EXECUTIVE OFFICER, GEMMA | AGXARGAN INC Option exercise | M | $31K 500 sh | Apr 22, 2026 traded Apr 21, 2026 |
| 5 | Feldman Jason D.SVP, IR, Treasury & Tax |  CRCrane CoOption exercise | M | — 162 sh | Apr 22, 2026 traded Apr 20, 2026 |
| 5 | Feldman Jason D.SVP, IR, Treasury & Tax | CRCrane Co Tax withholding | F | $16K 83 sh | Apr 22, 2026 traded Apr 20, 2026 |
| 5 | Skates SpenserDirector, CEO and President, 10% Owner |  AMPLAmplitude, Inc.Grant or award | A | — 1.32M sh | Apr 22, 2026 traded Apr 21, 2026 |
| 5 | Sehmi HarminderChief Financial Officer |  BZAIBlaize Holdings, Inc.Option exercise · 10b5-1 plan | M | $288K 505.1K sh | Apr 22, 2026 traded Apr 20, 2026 |
| 4 | Cross ShawnChief Financial Officer | PCRXPacira BioSciences, Inc. Open-market sale · 10b5-1 plan | SELL | $71K 2,845 sh | Apr 22, 2026 traded Apr 21, 2026 |
| 4 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Derivative conversion · 10b5-1 plan | C | — 200.0K sh | Apr 22, 2026 traded Apr 20, 2026 |
| 3 | Hyep IvanChief Financial Officer |  BCAXBicara Therapeutics Inc.Option exercise · 10b5-1 plan | M | — 9,200 sh | Apr 22, 2026 traded Apr 21, 2026 |
| 2 | Faga DanielDirector, President, CEO |  ANABANAPTYSBIO, INCGrant or award | A | — 133.4K sh | Apr 22, 2026 traded Apr 20, 2026 |
| 2 | Faga DanielDirector, President, CEO | ANABANAPTYSBIO, INC Grant or award | A | — 305.5K sh | Apr 22, 2026 traded Apr 20, 2026 |
| 2 | Faga DanielDirector, President, CEO | ANABANAPTYSBIO, INC Grant or award | A | — 11.0K sh | Apr 22, 2026 traded Apr 20, 2026 |
| 2 | Faga DanielDirector, President, CEO | ANABANAPTYSBIO, INC Disposition to issuer | D | — 2,321 sh | Apr 22, 2026 traded Apr 20, 2026 |
| 2 | Faga DanielDirector, President, CEO | ANABANAPTYSBIO, INC Grant or award | A | — 2,321 sh | Apr 22, 2026 traded Apr 20, 2026 |